Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • Nederlands
  • English
  • Home
  • Page

Pages related to "National Immunisation Programme"

Back to topic

SocioVax: social science research on vaccination

Most children in the Netherlands take part in the National Immunisation Programme. Participation is high enough that fewer people become seriously ill or die from infectious diseases. But the participation rate (or vaccination coverage) does not always stay steady at that high level. It is higher in some groups than in others. If fewer people are vaccinated, then the Netherlands will see more people becoming ill, and more outbreaks of the diseases that we vaccinate against. That is why RIVM launched the SocioVax research programme. Through SocioVax, we are researching what could help increase vaccination coverage. For example, we explore how communication about the National Immunisation Programme can better meet parents’ needs. And we look at ways to maximise ease of access to the vaccination programme so it is available to everyone.

News about the National Immunisation Programme

Rubella

Rubella is called ‘rodehond’ in Dutch. It is a highly contagious disease caused by the rubella virus. Usually, you do not become very ill. The virus spreads through coughing and sneezing. The virus is especially dangerous for pregnant women because it can lead to miscarriage or severe birth defects in their unborn child. Children receive 2 vaccinations against rubella, at 14 months and at the age of 9.

Hepatitis B

Hepatitis B is an inflammation of the liver caused by infection with the hepatitis B virus. It can be transmitted from mother to child at birth, through sexual contact or through contact with infected blood. Children who have contracted hepatitis B are at particular risk of becoming chronic carriers of the virus. Children receive a vaccination against hepatitis B four times before their first birthday.

Diphtheria

Diphtheria is a highly contagious infection with a bacterium. The bacterium can be transmitted through coughing or by touching. Usually, you become ill 2 to 5 days after infection. The bacterium often damages tissue, such as the skin or lungs. Before there was a vaccination against diphtheria in the Netherlands, many children died. It is included in the Dutch National Immunisation Programme. 

Tetanus

Tetanus, also known as lockjaw or trismus, is caused by the bacterium Clostridium tetani. As soon as the bacterium (which can be found in street refuse, for example) enters an open wound, a tetanus infection can be contracted. Since 1954, children have been receiving a vaccination against tetanus, 4 times before their first birthday and at the ages of 4 and 9.

Hib

Hib stands for Haemophilus influenzae type b, a bacterium that occurs occasionally in the nasal cavity of almost all people. The bacterium usually does not pose a danger and you do not become ill or it remains limited to a runny nose, strep throat, ear infection or sinusitis. In young children, the infection can be serious and cause pneumonia, meningitis or a life-threatening throat infection. The vaccination against Hib diseases has been part of the National Immunisation Programme since 1993. Children receive four vaccinations against Hib before their first birthday.

Polio

Surveillance and Developments

Annually, RIVM publishes an overview of surveillance data and scientific developments of the 13 infectious diseases against which the Dutch National Immunisation Programme (RVP in Dutch) vaccinates. The report on Surveillance and Developments also contains information about infectious diseases that are not (yet) included in the National Immunisation Programme, but for which a vaccine is available, such as chickenpox and shingles. 

Pagination

  • Current page 1
  • Page 2
  • › Next ›
  • » Last »

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon